Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results
Optinose (NASDAQ:OPTN) will report its fourth quarter 2020 financial results and provide corporate updates on March 3, 2021, before market opening.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Optinose (NASDAQ:OPTN) will report its fourth quarter 2020 financial results and provide corporate updates on March 3, 2021, before market opening. A conference call with the leadership team is scheduled for 8:00 a.m. Eastern Time on the same day. CEO Peter Miller will present a company overview at the Cowen 41st Annual Health Care Conference on March 4, 2021, at 1:30 p.m. Eastern Time. Investors can access the conference call and webcast through the company's website, with replays available for a limited time.
Positive
- Scheduled reporting of fourth quarter 2020 financial results may boost investor confidence.
- Participation in the Cowen 41st Annual Health Care Conference provides visibility to investors.
Negative
- None.
Details
News Market Reaction – OPTN
The recorded move for OPTN in the trading session of this news was +1.90%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call and Webcast to be held March 3, 2021 at 8:00 a.m. Eastern Time
Company to Present at the Cowen 41st Annual Health Care Conference on March 4, 2021
YARDLEY, Pa., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth quarter 2020 and corporate updates, before market open on Wednesday, March 3, 2021.
Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Wednesday, March 3, 2021.
To participate on the conference call, please dial (866) 916-4761 from the U.S. or +1 (409) 216-6496 from outside the U.S. In addition, following the completion of the call, a telephone replay will be accessible until Wednesday, March 10, 2021 by dialing (855) 859-2056 from the U.S. or +1 (404) 537-3406 from outside the U.S. and entering conference ID #9833299. A simultaneous webcast of the call and presentation can be accessed by visiting the Investors section of Optinose’s website at www.optinose.com. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.
Cowen 41st Annual Health Care Conference
In addition, the Company announced that announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Cowen 41st Annual Health Care Conference on Thursday, March 4, 2021, at 1:30 p.m. Eastern Time.
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A replay of the webcast will be available for 30 days following the conclusion of the event.
About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.